Rose LifeScience introduces new line of accessible cannabis products under “Promenade” brand

1.5 min readPublished On: February 12th, 2022By

HUNTINGDON, QC – Major Québec cannabis producer, distributer, and marketer ROSE LifeScience Inc. announced today the rollout of its newest brand, Promenade. The Promenade line will be commercialized through the Société Québécoise de Cannabis (SQDC). Under the new brand comes the introduction of two new products thanks to the ROSE offering.

Promenade’s inaugural products include Pennywise 1:1 and Pine Tar Kush; strains which are sustainably grown in hydroponics.

Pennywise 1:1 is a hydroponically cultivated genetic cross between Harlequin and Jack the Ripper. Its main feature is an equal balance between THC and CBD. Classified as a hybrid, the 3.5g dried flower includes dominant terpenes myrcene, guaiol and bisabolol and carries aromas which are sweet, earthy and woody. This product is available at $20.00.

Also grown hydroponically, Pine Tar Kush comes in a 28g dried flower format. Producing fern green buds covered with trichomes, this indica strain promotes woody, skunk and diesel aromas. This product is available at $125.80.

“ROSE prides itself with a deeply rooted history in Québec and a commitment to offering quality products to consumers. Our new line from Promenade not only proves this, but it makes good products more accessible. This is why we work so hard to deliver quality offerings for the Québec market,” stated ROSE President and CEO Davide Zaffino.

The new Promenade line of cannabis products hit virtual shelves this week on the SQDC website and adds itself to the already robust portfolio from ROSE LifeScience.

“The quality of our products is once again on display. We are proud of this, and are very excited to continue expanding Promenade with more new offerings,” added Mr. Zaffino.

(This information is primarily sourced from ROSE LifeScience.  Highly Capitalized has neither approved nor disapproved the contents of this news release. Read our Disclaimer here).

About the Author: HCN News Team

The News Team at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.

Share This Story, Choose Your Platform!